1. Improvement in Dasatinib-Induced Proteinuria after Switching to Nilotinib: A Case Report
   Joohee Jeon et al, 2023, The Korean Journal of Medicine CrossRef
2. Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension
   Zhengqing Ba et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
3. Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites
   Anne Robdrup Tinning et al, 2018, Hypertension CrossRef
4. Team-Based Approach to Management of Hypertension Associated with Angiogenesis Inhibitors
   Shreya Patel et al, 2020, Journal of Cardiovascular Translational Research CrossRef